financetom
Business
financetom
/
Business
/
Monster Beverage's Strong Q3 Seen Largely Priced In, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Monster Beverage's Strong Q3 Seen Largely Priced In, UBS Says
Nov 7, 2025 12:24 PM

03:14 PM EST, 11/07/2025 (MT Newswires) -- Monster Beverage ( MNST ) delivered a strong Q3 but further upside appears largely priced into the stock, UBS Securities said.

The company reported Q3 earnings per share of $0.55, topping UBS and Street estimates of $0.48, and the brokerage said Thursday in a note that a quarter-to-date read was broadly in line and positions the company for a likely strong Q4.

Gross margins held at 55.7% despite tariff-related cost pressures, supported by recent channel- and package-specific pricing effective Nov. 1 and improved efficiencies, the firm said. The brokerage also flagged potential margin upside from the expansion of concentrate-based affordable energy products.

UBS now sees about 12% organic revenue growth in Q4, with continued momentum in both the US and international markets.

However, it cautioned that with shares trading near 32 times next-twelve-months EPS, the upside "is largely priced in," and that greater visibility on further upside to estimates or a more attractive entry point would be needed before turning more constructive.

UBS lifted its 12-month price target to $75 from $72 and maintained a neutral rating.

Shares of Monster Beverage ( MNST ) were up more than 6% in recent Friday trading.

Price: 70.46, Change: +4.15, Percent Change: +6.26

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Viavi Solutions Insider Sold Shares Worth $761,842, According to a Recent SEC Filing
Viavi Solutions Insider Sold Shares Worth $761,842, According to a Recent SEC Filing
Jun 6, 2025
12:44 PM EDT, 06/06/2025 (MT Newswires) -- Ilan Daskal, Executive Vice President, CFO, on June 04, 2025, sold 82,095 shares in Viavi Solutions ( VIAV ) for $761,842. SEC Filing: https://www.sec.gov/Archives/edgar/data/912093/000091209325000075/xslF345X05/form4.xml Price: 9.46, Change: +0.15, Percent Change: +1.61 ...
Mgic Investment Insider Sold Shares Worth $781,110, According to a Recent SEC Filing
Mgic Investment Insider Sold Shares Worth $781,110, According to a Recent SEC Filing
Jun 6, 2025
12:45 PM EDT, 06/06/2025 (MT Newswires) -- Salvatore A Miosi, President & COO, on June 05, 2025, sold 30,000 shares in Mgic Investment ( MTG ) for $781,110. Following the Form 4 filing with the SEC, Miosi has control over a total of 694,245 common shares of the company, with 309,401 shares held directly and 384,844 controlled indirectly. SEC Filing:...
Phathom Pharmaceuticals Shares Surge After FDA Grants 10-Year Exclusivity for Acid-Reducing Drug
Phathom Pharmaceuticals Shares Surge After FDA Grants 10-Year Exclusivity for Acid-Reducing Drug
Jun 6, 2025
12:54 PM EDT, 06/06/2025 (MT Newswires) -- Phathom Pharmaceuticals ( PHAT ) shares jumped nearly 104% in recent Friday trading after the company said the US Food and Drug Administration approved its citizen petition to grant full New Chemical Entity exclusivity for its acid-reducing drug, Voquezna, or vonoprazan. The FDA confirmed it will update the Orange Book to reflect a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved